Obesity Surgery最新文献

{"title":"Is it Safe to Perform Concomitant Cholecystectomy in Patients With Confirmed Gallbladder Disease Undergoing Metabolic and Bariatric Surgery? An Updated Meta-Analysis.","authors":"Giulia Almiron da R Soares, Amanda Godoi, Pedro C A Reis, Ana Gabriela Ponte Farias, Gabriela R Brandao, Bernardo Fontel Pompeu, Mariana Pereira, Victor Kenzo Ivano, Sergio Mazzola Poli de Figueiredo","doi":"10.1007/s11695-025-07821-9","DOIUrl":"https://doi.org/10.1007/s11695-025-07821-9","url":null,"abstract":"<p><strong>Introduction: </strong>Obesity is a global public health issue, and metabolic and bariatric surgery (MBS) remains most effective intervention for achieving and maintaining long-term weight loss. However, rapid weight loss following MBS increases the risk of gallstone formation. Concomitant cholecystectomy (CC) during MBS has been proposed to mitigate this risk, but recent studies present conflicting evidence regarding its safety and efficacy, leaving no clear consensus.</p><p><strong>Methods: </strong>We conducted a meta-analysis by systematically searching MEDLINE, Cochrane Central, Embase, and ClinicalTrials.gov for studies comparing CC plus BS versus BS alone. Odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Statistical analyses were performed with Review Manager v5.4 and RStudio v4.3.3.</p><p><strong>Prospero id: </strong>CRD42023480360.</p><p><strong>Results: </strong>We included 26 studies encompassing 656,830 patients with confirmed gallstones, among whom 34,409 (5.2%) underwent CC.The mean age was 41.5 years, and 79.2% were female. Patients undergoing CC + MBS had increased postoperative bleeding (OR 1.31; 95% CI 1.06-1.62; p = 0.01), wound complications (OR 1.61; 95% CI 1.34-1.95; p < 0.01), respiratory complications (OR 1.49; 95% CI 1.13-1.95; p < 0.01), and anastomotic complications (OR 1.86; 95% CI 1.28-2.70; p < 0.01). No significant differences in operation time, rates of postoperative mortality, length of hospital stay, and vein thrombosis were found between groups.</p><p><strong>Conclusion: </strong>CC during MBS increases operative time and postoperative complications, though only anastomotic complications are clinically significant. Therefore, CC should be reserved for high-risk or symptomatic patients and avoided in bariatric procedures involving an anastomosis due to the elevated risk of complications.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and Risk Factors of In-Hospital Gastrointestinal-Related Complications Following Bariatric Surgery: A Retrospective Nationwide Inpatient Sample Database Study.","authors":"Lingli Liang, Luansheng Liang, Yangguang Huang, Haimao Liang, Jianghua Su, Yanling Zhou","doi":"10.1007/s11695-025-07840-6","DOIUrl":"https://doi.org/10.1007/s11695-025-07840-6","url":null,"abstract":"<p><strong>Background: </strong>Obesity is associated with numerous serious physiological and psychological health problems. Bariatric surgery (BS) remains the most effective treatment for obesity, but early postoperative gastrointestinal complications may require additional surgical intervention. The objective of this study was to analyze gastrointestinal-related complications (GRCs) and their risk factors following BS, including sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB), using a nationwide database.</p><p><strong>Methods: </strong>An analysis of the Nationwide Inpatient Sample data from 2010 to 2019 was conducted to compare patients following BS with versus without postoperative GRCs. Variables included demographics, hospital characteristics, length of stay, costs, comorbidities, and complications. Risk factors were identified through stepwise multivariate logistic regression.</p><p><strong>Results: </strong>Among 323,066 BS patients, 12,248 (3.79%) developed GRCs, with a decreasing trend observed over the study period. Common complications included gastrointestinal bleeding (1.37%), bowel obstruction (1.84%), and anastomotic issues (0.99%). Significant risk factors included advanced age, anemia (deficiency and chronic blood loss), cardiovascular conditions (heart failure, valve disease, peripheral vascular disorders), coagulation abnormalities, rheumatoid arthritis or collagen vascular diseases, drug abuse, electrolyte imbalances, neurological conditions, renal failure, non-bleeding peptic ulcer disease, and weight loss. Interestingly, liver disease emerged as a risk factor for GRCs after SG while acting as a protective factor for GRCs after RYGB.</p><p><strong>Conclusion: </strong>Understanding the risk factors for GRCs after BS would allow for improved patient management and clinical outcomes.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Small Bowel Perforation in Roux-en-Y Gastric Bypass (RYGB) Secondary to Apolipoprotein A-IV (AApoA-IV) Type Amyloidosis.","authors":"Mona Zhi Ling Mai Jiang, Stefaan De Clercq","doi":"10.1007/s11695-025-07814-8","DOIUrl":"https://doi.org/10.1007/s11695-025-07814-8","url":null,"abstract":"<p><strong>Background: </strong>ApoA-IV amyloidosis is a rare disease that involves the deposition of ApoA-IV protein aggregates in tissues. It commonly presents as cardiac or renal disease, but can, in rare cases, cause small bowel perforation.</p><p><strong>Methods: </strong>This study describes a case of ApoA-IV type amyloidosis causing small bowel perforation after conversion of a sleeve gastrectomy (SG) into a RYGB in a Crohn's disease (CD) and rheumatoid arthritis (RA) patient. It also considers the indications for bariatric and anti-reflux surgery in the setting of co-morbid inflammatory bowel disease (IBD), gastro-oesophageal reflux disease (GORD), and obesity.</p><p><strong>Results: </strong>Obesity can reduce the efficacy of IBD medications and drives a pro-inflammatory state that may worsen IBD, however IBD patients present an operative challenge due to risk of more intestinal adhesions, potential intolerance to intestinal bypass, and risk of affecting options for future bowel resections if required. SG is often chosen over RYGB for CD patients due to limited short-term complications. However, when considering co-morbid GORD, the long-term risk of medication resistant GORD, erosive oesophagitis, and Barrett's oesophagus with SG is significant, especially given that SG is an irreversible procedure.</p><p><strong>Conclusion: </strong>There is growing evidence that bariatric surgery in IBD patients is both safe and effective, however the decision to perform bariatric surgery in an IBD patient involves consideration of the intricate interplay between obesity and IBD.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Comprehensive Multidisciplinary Metabolic Center to Treat Patients with Obesity in the Allegheny Health Network.","authors":"George M Eid, Melissa Schultz, Fahad Zubair","doi":"10.1007/s11695-025-07813-9","DOIUrl":"https://doi.org/10.1007/s11695-025-07813-9","url":null,"abstract":"<p><p>Multidisciplinary treatment approaches are common for chronic diseases like cardiovascular disease, but obesity treatment remains largely siloed. Increasing efficiency in obesity treatment is crucial to improving financial and clinical outcomes. The Allegheny Health Network established a metabolic center consisting of bariatric surgeons, specialists in bariatric medicine, and endocrinologists specializing in diabetes care, who together developed an obesity treatment algorithm to address this need and to improve clinical outcomes through research, continuing education, and primary care outreach. This correspondence provides insights into the development and implementation of the metabolic center and presents the algorithm used to select a patient's obesity treatment based on their individual phenotype, characteristics, and contraindications. The Alleghany Health Network may be used as a model for the necessary development of similar comprehensive, multidisciplinary obesity specialty centers.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Body Composition Changes and Predictor of Weight Loss in Short Term after Sleeve Gastrectomy.","authors":"Guangnian Ji, Chuanrong Zhu, Shaochuang Wang, Lingling Zhou, Jinsheng Wu","doi":"10.1007/s11695-025-07830-8","DOIUrl":"https://doi.org/10.1007/s11695-025-07830-8","url":null,"abstract":"<p><strong>Background: </strong>Metabolic bariatric surgery is the most effective treatment for achieving sustainable weight loss in patients with severe obesity. However, changes in body composition, particularly limb composition, after sleeve gastrectomy (SG) in the Asian population have not been widely reported. Additionally, few studies have focused on predicting short-term weight loss following SG.</p><p><strong>Methods: </strong>We evaluated 159 patients with obesity who underwent SG between May 2020 and June 2023 at our hospital. Each patient's demographic, anthropometric, laboratory, and body composition data were collected at baseline and at 1, 3, 6, and 12 months post-surgery. Logistic regression analysis was used to identify independent predictors of weight loss.</p><p><strong>Results: </strong>The mean age of the 159 patients was 30.4 ± 7.7 years, with 78.0% being female. Compared to baseline values, anthropometric parameters and metabolic profiles improved significantly after surgery. All body composition indices decreased, with fat mass (FM, in kg and percentage), visceral fat area (VFA), and obesity degree continuing to decline up to 1 year postoperatively. The percentage of excess weight loss (EWL%) reached 55.7 ± 17.6% at 3 months, meeting the standard for effective weight loss. Eleven factors were negatively correlated with EWL%, and obesity degree was identified as an independent predictor of weight loss (OR: 0.951, P = 0.001). The area under the receiver operating characteristic curve for obesity degree was 0.781 (95% CI: 0.668-0.894, P < 0.001), with sensitivity and specificity values of 0.643 and 0.857, respectively, and a cutoff value of 193.5%.</p><p><strong>Conclusions: </strong>Sleeve gastrectomy significantly improved anthropometric and metabolic variables, achieving effective short-term weight loss. Body composition changes were observed across the whole body, limbs, and trunk. Obesity degree was closely associated with effective weight loss after surgery and may serve as a potentially useful metric for clinical practice.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143743257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Effect of Preoperative Single-Dose Tranexamic Acid on Bleeding and Thromboembolic Events Following Bariatric Surgery.","authors":"Nachum Emil Eliezer Lourie, Amram Kupietzky, Ata Maden, Shlomit Sharvit, Ariel Ronen, Melisa Umansky, Ido Mizrahi, Haggi Mazeh, Danny Ben-Zvi, Ronit Grinbaum","doi":"10.1007/s11695-025-07764-1","DOIUrl":"https://doi.org/10.1007/s11695-025-07764-1","url":null,"abstract":"<p><strong>Background: </strong>Intravenous tranexamic acid (TXA) has been shown to reduce perioperative blood loss and transfusion needs in various surgeries. However, its effectiveness in minimizing these complications during metabolic bariatric surgery remains unclear. This study aimed to determine whether a single prophylactic dose of intravenous TXA administered before metabolic bariatric surgery reduces the risk of perioperative hemorrhage.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on patients who underwent metabolic bariatric surgery at our institute from 2019 to 2022, with routine TXA administration starting in 2021. A comparison was made between the TXA and non-TXA groups, with all surgeries performed by a single surgical team.</p><p><strong>Results: </strong>A total of 901 patients were included, with 560 (62.2%) in the non-TXA group and 341 (37.8%) in the TXA group. There were no significant differences between groups in age, sex, or preoperative BMI, although a higher proportion of post-2021 patients underwent gastric bypass. No significant differences were observed in the percentage of patients with bloody surgical drains (4.2% vs. 4.9%, p = 0.662), transfusion need (1.5% vs. 1.6%, p = 1), re-operations for bleeding (3.2% vs. 2.3%, p = 0.582), or postoperative thromboembolic events (0.2% vs. 0%, p = 1.0).</p><p><strong>Conclusions: </strong>A single dose of intravenous TXA did not reduce postoperative bleeding in bariatric patients, nor were there significant differences in thromboembolic events or mortality between groups. Further randomized controlled trials are needed to confirm or refute TXA's effectiveness in reducing this potentially life-threatening complication.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143736048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immediately-Patent Magnetic Duodeno-Ileal Anastomosis (IMPA-DI): The First-in-Human Study.","authors":"Mohit Bhandari, Manoel Galvao Neto, Vitor Ottoboni Brunaldi, Mahak Bhandari, Winnie Mathor, Manoj Reddy, Andre Teixeira, Erik B Wilson","doi":"10.1007/s11695-025-07823-7","DOIUrl":"https://doi.org/10.1007/s11695-025-07823-7","url":null,"abstract":"<p><strong>Background: </strong>Duodeno-ileal anastomoses are technically challenging and associated with high complication rates, limiting their adoption in bariatric surgery despite their efficacy in weight loss. Magnetic compression anastomoses (MCAs) have emerged as a promising technique, promoting tissue fusion and reducing risks of bleeding and leakage. However, delayed patency limits their application. The OTOLoc™ system, combined with Flexagon self-forming magnets (SFMs), addresses this limitation by enabling immediate patency during healing. This study reports the first-in-human experience of immediately patent magnetic duodeno-ileal anastomosis (IMPA-DI) using these novel devices during single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S).</p><p><strong>Methods: </strong>This single-center, observational study evaluated the feasibility and short-term safety of IMPA-DI. Seven adult patients with moderate to severe obesity were included. The SFM assembly, coupled with the OTOLoc™ system, was laparoscopically deployed to create an immediately patent duodeno-ileal anastomosis. Primary endpoints were technical success and freedom from anastomosis-related adverse events (AEs) within 30 days. Secondary outcomes included procedural metrics and overall safety.</p><p><strong>Results: </strong>All seven procedures were successfully completed, with a median overall duration of 58 min and magnet placement duration of 12 min. Three intraoperative AEs (serosal and liver injuries, staple line bleeding) were unrelated to IMPA and resolved without complications. All patients resumed liquid diets within 2 days, and no anastomosis-related AEs were observed within 30 days. All devices were naturally expelled without complications.</p><p><strong>Conclusions: </strong>This first-in-human study demonstrates the feasibility, safety, and efficiency of the IMPA-DI approach using Flexagon SFMs and the OTOLoc™ system. The immediate patency and straightforward deployment highlight the potential for broader application in challenging anastomotic sites. While limited by the small sample size and single-center design, the results underscore the promise of magnetic compression anastomoses. Further studies are warranted to validate these findings and explore long-term outcomes.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143720561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Obstacles Faced by Young Bariatric Surgeons in Greece: A Call for Change.","authors":"Athanasios Pantelis, Georgia Doulami","doi":"10.1007/s11695-025-07820-w","DOIUrl":"https://doi.org/10.1007/s11695-025-07820-w","url":null,"abstract":"","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143720737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Omentopexy in Sleeve Gastrectomy: The Game Changer for Minimizing Complications and Surgery Time in Revisional Roux-en-Y Gastric Bypass.","authors":"Emre Teke, Anıl Ergin, Yasin Güneş, Nuriye Esen Bulut, Mehmet Mahir Fersahoğlu","doi":"10.1007/s11695-025-07822-8","DOIUrl":"https://doi.org/10.1007/s11695-025-07822-8","url":null,"abstract":"<p><strong>Background: </strong>Laparoscopic sleeve gastrectomy (LSG) is a widely performed bariatric surgery; however, some patients experience inadequate weight loss or weight regain, requiring revisional bariatric surgery such as Roux-en-Y gastric bypass (RYGB). Omentopexy, a technical variation during LSG, may influence long-term outcomes and the complexity of subsequent surgeries. This study aims to evaluate the impact of omentopexy during LSG on perioperative outcomes and surgery duration in patients requiring revisional RYGB.</p><p><strong>Methods: </strong>This retrospective cohort study analyzed 62 patients who underwent revisional RYGB following primary LSG between January 2015 and January 2024. Patients were divided into two groups based on whether omentopexy was performed during the initial LSG. The primary outcomes assessed were perioperative complications, intrathoracic gastric migration (IGM), and surgery duration during RYGB. Secondary outcomes included hospital stay length and 30-day readmission rates.</p><p><strong>Results: </strong>Of the 62 patients, 56 were female and 6 were male, with a mean age of 44.3 years. The mean body mass index (BMI) was 39.5 kg/m². The omentopexy group (O-LSG) exhibited a significantly lower rate of perioperative complications (7.6%) compared to the non-omentopexy group (NO-LSG) (25%, p < 0.05). Intrathoracic gastric migration was observed in 13.8% of NO-LSG patients, while no cases were found in the O-LSG group. Additionally, surgery duration was significantly shorter in the O-LSG group (p < 0.05). No significant difference was found between the groups regarding hospital stay length or 30-day readmission rates.</p><p><strong>Conclusions: </strong>Omentopexy during primary LSG is associated with reduced perioperative complications, shorter surgery durations, and lower rates of intrathoracic gastric migration during revisional RYGB. These findings suggest that performing omentopexy during LSG may simplify revisional procedures and improve patient outcomes.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143720743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and Feasibility of Same-Day Discharge After Primary Bariatric Surgery and the Value of Remote Monitoring with the Healthdot.","authors":"Kayleigh Ann Martina van Dam, Geert Henricus Jozef Martinus Verkoulen, Pieter Petrus Henricus Lucien Broos, Evelien de Witte, Jan Willem M Greve, Evert-Jan Gijsbert Boerma","doi":"10.1007/s11695-025-07828-2","DOIUrl":"https://doi.org/10.1007/s11695-025-07828-2","url":null,"abstract":"<p><strong>Background: </strong>Annually, more than 12,500 bariatric procedures are performed in the Netherlands. Same-day discharge (SDD) has been implemented in several surgical procedures and was recently introduced in bariatric metabolic surgery (BMS). However, the best way to safely facilitate this introduction is a subject of debate. This study aims to assess the feasibility of SDD in selected patients undergoing primary BMS and the value of remote monitoring with a wireless vital sign monitoring system (Healthdot).</p><p><strong>Methods: </strong>This retrospective study included all primary sleeve gastrectomy and Roux-en-Y gastric bypass procedures in the first year after the introduction of SDD in a large teaching hospital in the Netherlands. SDD patients were remotely monitored postoperatively for 7 days using the Healthdot which measured vital signs continuously. The primary outcome was the success rate of SDD. Secondary outcomes included readmissions, complication rate, and Healthdot alarms.</p><p><strong>Results: </strong>Out of 813 consecutive primary bariatric procedures between March 2022 and March 2023, there were 514 eligible patients of whom 260 were scheduled for SDD. Successful SDD was achieved in 246 patients (94.6%). Eight patients were readmitted within 48 h resulting in a success rate of 91.5%. Among 217 patients (83.5%) who went home with the Healthdot device, 28 alarms occurred of which 26 did not have a complication. In 11 other patients, a complication occurred without any alarms during the 7-day period.</p><p><strong>Conclusions: </strong>SDD after primary bariatric procedures is considered safe if specific selection and discharge criteria are maintained. The Healthdot is found to be ineffective in predicting complications in this patient group.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143720745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}